INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 458m ago
HOUSE PTR58m ago
SEC 13F58m ago
ROBINHOOD CHAIN58m ago
FJ
Corporate insider

Fitzpatrick Jennifer

Chief Legal OfficerCIK 0002061851

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells0 / 3
Max Insider Score23
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Grant or award
A—
28.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Sionna Therapeutics, Inc.Chief Legal Officer · Dec 9, 2025
5
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Disposition to issuer
D
—
103.1K sh
Sep 17, 2026
Sep 18, 2026
traded Sep 17, 2026
+1d
SEC FORM 4

Evidence

5
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Grant or award
A—
103.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

5
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Grant or award
A—
28.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

3
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.3K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

19
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$447K
10.3K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

0
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$63K
10.3K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

0
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$63K
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC FORM 4

Evidence

19
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$347K
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC FORM 4

Evidence

3
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC FORM 4

Evidence

5
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Grant or award
A—
103.1K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

2
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$63K
10.3K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

23
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$415K
10.3K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

7
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.3K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence